Cargando…

Policy options discussed for pricing novel COVID-19 vaccines/treatment

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347757/
https://www.ncbi.nlm.nih.gov/pubmed/32834723
http://dx.doi.org/10.1007/s40274-020-6973-4
_version_ 1783556655632351232
collection PubMed
description
format Online
Article
Text
id pubmed-7347757
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73477572020-07-10 Policy options discussed for pricing novel COVID-19 vaccines/treatment PharmacoEcon Outcomes News News Item Springer International Publishing 2020-07-11 2020 /pmc/articles/PMC7347757/ /pubmed/32834723 http://dx.doi.org/10.1007/s40274-020-6973-4 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
Policy options discussed for pricing novel COVID-19 vaccines/treatment
title Policy options discussed for pricing novel COVID-19 vaccines/treatment
title_full Policy options discussed for pricing novel COVID-19 vaccines/treatment
title_fullStr Policy options discussed for pricing novel COVID-19 vaccines/treatment
title_full_unstemmed Policy options discussed for pricing novel COVID-19 vaccines/treatment
title_short Policy options discussed for pricing novel COVID-19 vaccines/treatment
title_sort policy options discussed for pricing novel covid-19 vaccines/treatment
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347757/
https://www.ncbi.nlm.nih.gov/pubmed/32834723
http://dx.doi.org/10.1007/s40274-020-6973-4